SCHEMBL6750554

SCHEMBL6750554

C=C[CH]NS(=O)(=O)[14CH2]C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721829 0.65
SCHEMBL15561929 0.65
SCHEMBL1040932 0.60
SCHEMBL1528079 0.60
SCHEMBL5685900 0.58
SCHEMBL14863731 0.52
SCHEMBL3631213 0.52
Sulfuric Acid SCHEMBL895305 0.47
Butadiene SCHEMBL21219232 0.47
Acrolein SCHEMBL21612829 0.46

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020115864-A1 Potentiators of glutamate receptor function ARNOLD MACKLIN BRIAN (US) 2002-08-22 US claimed
JP-2001511781-A 2001-08-14 JP claimed
WO-2000006157-A1 SULPHONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2000-02-10 WO claimed
WO-1998033496-A1 SULPHONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1998-08-06 WO claimed
US-20040157842-A1 Sulphonamide derivatives ARNOLD MACKLIN BRIAN (US) 2004-08-12 US disclosed
US-6713516-B2 GLUTAMATE RECEPTOR POTENTIATION ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-20030171350-A1 Sulphonamide derivatives ARNOLD MACKLIN BRIAN (US) 2003-09-11 US disclosed
WO-1998033496-A1 SULPHONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1998-08-06 WO disclosed